<?xml version="1.0" encoding="utf-8" ?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
         xmlns:dc="http://purl.org/dc/elements/1.1/"
         xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
         xmlns="http://purl.org/rss/1.0/">




    



<channel rdf:about="http://www.exac.com/home/RSS">
  <title>Experience Exactech. A Great Day in the O.R.</title>
  <link>http://www.exac.com</link>
  
  <description>
    
       Corporate Home Page
       
  </description>
  
  
  
            <syn:updatePeriod>daily</syn:updatePeriod>
            <syn:updateFrequency>1</syn:updateFrequency>
            <syn:updateBase>2008-05-15T12:34:47Z</syn:updateBase>
        
  
  <image rdf:resource="http://www.exac.com/spacer.gif"/>

  <items>
    <rdf:Seq>
        
            <rdf:li rdf:resource="http://www.exac.com/news/exactech-q3-revenue-up-27-to-37.9m-net-income-2.1m"/>
        
        
            <rdf:li rdf:resource="http://www.exac.com/news/exactech-updates-third-quarter-financial-guidance.-announces-q3-earnings-and-conference-call"/>
        
    </rdf:Seq>
  </items>

</channel>

    <item rdf:about="http://www.exac.com/news/exactech-q3-revenue-up-27-to-37.9m-net-income-2.1m">        <title>Exactech Q3 Revenue Up 27% to $37.9M; Net Income $2.1M</title>        <link>http://www.exac.com/news/exactech-q3-revenue-up-27-to-37.9m-net-income-2.1m</link>        <description>GAINESVILLE, Fla. -- October 28, 2008 -- Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today that revenue for the third quarter of 2008 increased 27% to $37.9 million from $30.0 million in the third quarter of 2007. Diluted earnings per share for the quarter were $0.16 based on net income of $2.1 million. This compares with net income of $2.5 million or $0.21 diluted EPS a year ago. As previously announced, the net income includes pre-tax legal expenses and costs of $1.2 million related to the ongoing Department of Justice inquiry. 
</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>kmiranda</dc:creator>        <dc:rights></dc:rights>                    <dc:subject>Press Releases</dc:subject>                <dc:date>2008-10-28T21:07:13Z</dc:date>        <dc:type>News Item</dc:type>    </item>
    <item rdf:about="http://www.exac.com/news/exactech-updates-third-quarter-financial-guidance.-announces-q3-earnings-and-conference-call">        <title>Exactech Updates Third Quarter Financial Guidance. Announces Q3 Earnings and Conference Call</title>        <link>http://www.exac.com/news/exactech-updates-third-quarter-financial-guidance.-announces-q3-earnings-and-conference-call</link>        <description>GAINESVILLE, Fla. -- October 14, 2008 -- Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, said today that revenue for the quarter, which ended September 30, will be approximately $37.9 million, an increase of 26% and within the previously announced range. Earnings for the third quarter of 2008 will be below the company’s original estimates of $0.21-$0.23 diluted earnings per share and will be approximately $0.15 diluted earnings per share due to higher than expected legal expenses in the quarter of approximately $1.4 million, or $0.07 per share after taxes. 
</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>admin</dc:creator>        <dc:rights></dc:rights>                    <dc:subject>Press Releases</dc:subject>                <dc:date>2008-10-14T18:29:50Z</dc:date>        <dc:type>News Item</dc:type>    </item>




</rdf:RDF>
